fbpx

Research Grants

The Holckner Family CF Impact Grant

Next round opens on 23rd of June 2025

<<< Guidelines >>>

Cure4 Cystic Fibrosis Foundation proudly funds outstanding research that aims to accelerate the delivery of life-extending and life-transforming solutions for people living with cystic fibrosis. We are committed to supporting projects that lead to meaningful clinical outcomes.

From the outset, we prioritise innovative, high-impact research with a clear pathway to deliver tangible benefits for the cystic fibrosis community. We seek researchers who are not only driven by discovery but are also dedicated to translating their findings into real-world impact.

To guide our funding decisions, Cure4CF receives independent advice from a dedicated Research Advisory Committee. This expert panel plays a vital role in helping us identify and assess high-quality, impactful research. These advisory services are generously provided to Cure4CF at no cost.

Our sole mission is to fund innovative research that builds on existing knowledge and demonstrates a clear pathway and commitment to translational impact.

In 2025, Cure4CF will invest up to $1 million in advancing cystic fibrosis research. Funding will be offered through two streams:

  • Development Projects: Designed for high potential projects that lay the groundwork for future translational research and/or applications to larger funding schemes.
  • Major Collaborative Projects: Targeting more advanced research projects, this stream supports initiatives with strong multi-institutional collaboration, clear translational pathways, and the potential for significant clinical impact.

Further details on each funding stream are available in the Guidelines document.

By uniting our community and investing strategically in research, we are working toward our vision of a cure for cystic fibrosis.

For questions about the application process or technical support, please contact us at grants@cure4cf.org.

In 2025 Cure4CF will provide up to $1,000,000 to advance medical innovations in cystic fibrosis.